Is It Worth Investing in Ulta (ULTA) Based on Wall Street's Bullish Views? — Positive
ULTA Zacks Investment Research — January 16, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Regions Financial (RF) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral
RF Zacks Investment Research — January 16, 2026While the top- and bottom-line numbers for Regions Financial (RF) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
State Street (STT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
STT Zacks Investment Research — January 16, 2026Although the revenue and EPS for State Street (STT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The PNC Financial Services Group (PNC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates — Positive
PNC Zacks Investment Research — January 16, 2026The headline numbers for The PNC Financial Services Group (PNC) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Constellation Energy Corporation (CEG) Is Considered a Good Investment by Brokers: Is That True? — Positive
CEG Zacks Investment Research — January 16, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Here's What Key Metrics Tell Us About M&T Bank (MTB) Q4 Earnings — Neutral
MTB Zacks Investment Research — January 16, 2026While the top- and bottom-line numbers for M&T Bank (MTB) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Is It Worth Investing in Marvell (MRVL) Based on Wall Street's Bullish Views? — Positive
MRVL Zacks Investment Research — January 16, 2026When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet — Neutral
ISRG Zacks Investment Research — January 16, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wall Street Bulls Look Optimistic About Seanergy Maritime Holdings (SHIP): Should You Buy? — Neutral
SHIP Zacks Investment Research — January 16, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Brokers Suggest Investing in Kinder Morgan (KMI): Read This Before Placing a Bet — Neutral
KMI Zacks Investment Research — January 16, 2026When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Wall Street Bulls Look Optimistic About Strategy (MSTR): Should You Buy? — Positive
MSTR Zacks Investment Research — January 16, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Brokers Suggest Investing in Workday (WDAY): Read This Before Placing a Bet — Neutral
WDAY Zacks Investment Research — January 16, 2026Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Wall Street Bulls Look Optimistic About Home Depot (HD): Should You Buy? — Neutral
HD Zacks Investment Research — January 16, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Brokers Suggest Investing in Tutor Perini (TPC): Read This Before Placing a Bet — Negative
TPC Zacks Investment Research — January 16, 2026The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience — Neutral
SKYE Newsfile Corp — January 16, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skye To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Skye between November 4, 2024 and October 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 16, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Skye Biosciences, Inc. ("Skye" …
Tech earnings loom as investors look for proof the AI boom is paying off — Neutral
MSFT Proactive Investors — January 16, 2026The coming technology earnings season will test a simple question: is the vast spending on artificial intelligence starting to deliver tangible returns? That is the core issue investors will be listening for as results roll in from the world's largest technology groups, according to a note this week from Wedbush.
We believe Ardent Health (ARDT) stock is worth considering: It is growing, generating cash, and is priced at a notable valuation discount. Companies of this caliber can utilize cash to drive further revenue growth, or simply reward their shareholders through dividends or buybacks.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute — Neutral
RZLT Newsfile Corp — January 16, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Rezolute to Contact Him Directly to Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 16, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ: RZLT).
Strength Seen in MKS (MKSI): Can Its 7.9% Jump Turn into More Strength? — Positive
MKSI Zacks Investment Research — January 16, 2026MKS (MKSI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Howmet's Margins Expand Despite Rising Costs: Will the Momentum Sustain? — Positive
HWM Zacks Investment Research — January 16, 2026HWM faces rising costs, but margin expansion, pricing strength and higher 2025 EBITDA guidance show profitability remains on track.